Compare NVDA & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVDA | PFE |
|---|---|---|
| Founded | 1993 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5T | 155.2B |
| IPO Year | 1998 | 2013 |
| Metric | NVDA | PFE |
|---|---|---|
| Price | $180.36 | $26.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 38 | 12 |
| Target Price | ★ $263.29 | $27.83 |
| AVG Volume (30 Days) | ★ 138.3M | 31.5M |
| Earning Date | 05-26-2026 | 05-04-2026 |
| Dividend Yield | 0.02% | ★ 6.40% |
| EPS Growth | ★ 66.67 | N/A |
| EPS | ★ 4.90 | 1.36 |
| Revenue | ★ $215,938,000,000.00 | $62,579,000,000.00 |
| Revenue This Year | $67.04 | N/A |
| Revenue Next Year | $29.67 | N/A |
| P/E Ratio | $37.38 | ★ $19.76 |
| Revenue Growth | ★ 65.47 | N/A |
| 52 Week Low | $86.63 | $20.92 |
| 52 Week High | $212.19 | $27.94 |
| Indicator | NVDA | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 47.27 |
| Support Level | $177.57 | $26.29 |
| Resistance Level | $184.36 | $26.74 |
| Average True Range (ATR) | 5.33 | 0.53 |
| MACD | -0.32 | -0.08 |
| Stochastic Oscillator | 23.64 | 28.87 |
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence to run large language models. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.